Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemiaTIBURCIO RIBEIRO, Ana Flávia; PRATCORONA, Marta; VALK, Peter J. M et al.Blood. 2012, Vol 119, Num 24, pp 5824-5831, issn 0006-4971, 8 p.Article

Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic valuePRATCORONA, Marta; ABBAS, Saman; SANDERS, Mathijs A et al.Haematologica (Roma). 2012, Vol 97, Num 3, pp 388-392, issn 0390-6078, 5 p.Article

High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patientsNOORDERMEER, Sylvie M; SANDERS, Mathijs A; GILISSEN, Christian et al.Blood. 2011, Vol 118, Num 20, pp 5613-5621, issn 0006-4971, 9 p.Article

Dicer1 deletion in myeloid-committed progenitors causes neutrophil dysplasia and blocks macrophage/dendritic cell development in miceFARSHID ALEMDEHY, Mir; VAN BOXTEL, Nicole G. J. A; DE LOOPER, Hans W. J et al.Blood. 2012, Vol 119, Num 20, pp 4723-4730, issn 0006-4971, 8 p.Article

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML) : association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. CommentaryGALLAGHER, Robert E; VERHAAK, Roel G. W; LOWENBERG, Bob et al.Blood. 2005, Vol 106, Num 12, pp 3681-3682, issn 0006-4971, 10 p.Article

Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemiaBEEKMAN, Renée; VALKHOF, Marijke G; LÖWENBERG, Bob et al.Blood. 2012, Vol 119, Num 22, pp 5071-5077, issn 0006-4971, 7 p.Article

Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entityTASKESEN, Erdogan; BULLINGER, Lars; SCHLENK, Richard F et al.Blood. 2011, Vol 117, Num 8, pp 2469-2475, issn 0006-4971, 7 p.Article